Tectonic Therapeutic, Inc. Common Stock (TECX) is a publicly traded Healthcare sector company. As of November 5, 2026, TECX trades at $19.40 with a market cap of $396.85M and a P/E ratio of -5.13. TECX moved -4.68% today. Year to date, TECX is -1.60%; over the trailing twelve months it is +17.97%. Its 52-week range spans $13.70 to $39.53. Analyst consensus is strong buy with an average price target of $69.75. Rallies surfaces TECX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TECX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $19.40 |
| Market Cap | $396.85M |
| P/E Ratio | -5.13 |
| EPS | $-4.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.53 |
| 52-Week Low | $13.70 |
| Volume | 84.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $-129.69M |
| Net Income | $-85.79M |
| Gross Margin | 0.00% |
8 analysts cover TECX: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $69.75.